Medicine
Jennifer M. Yamamoto, Helen R. Murphy
Abstract
The use of glucagon-like peptide-1 receptor agonists (GLP-1RA) is increasing worldwide, particularly among women of reproductive age. Whilst preliminary data are reassuring more data are regarding their potential risks and bene
Citation format
YAMAMOTO, Jennifer M.; MURPHY, Helen R. Technology and pregnancy. Diabetes Technology & Therapeutics, 2026, 28 2_suppl(2_suppl): 106S-113S.